Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

PAOLA GHIONE

Allopathic & Osteopathic Physicians Internal Medicine Medical Oncology

NPI
1730740556
CMS profile
8295509
Location
BUFFALO, NY

General Payments · PY2021–2024

$20,367.61

  • Reported across 20 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$13,995.19

14 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
ADC Therapeutics America, Inc. $11,054.27 9
Ipsen Biopharmaceuticals, Inc $2,720.21 2
Regeneron Pharmaceuticals, Inc. $127.32 1
Genmab U.S., Inc. $56.34 1
Genentech USA, Inc. $37.05 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2021 $2,346.25 2
PY2022 $1,527.37 2
PY2023 $2,498.80 2
PY2024 $13,995.19 14

Payment records · PY2024 (14)

Sorted by paying entity, then date · as published by CMS

Program year 2024 202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ADC Therapeutics America, Inc. $564.00 09/17/2024 Travel and Lodging Undisputed 01/23/2026 1121188976 CMS
ADC Therapeutics America, Inc. $120.03 09/27/2024 Food and Beverage Undisputed 01/23/2026 1121188966 CMS
ADC Therapeutics America, Inc. $50.01 09/27/2024 Food and Beverage Undisputed 01/23/2026 1121188968 CMS
ADC Therapeutics America, Inc. $43.01 09/27/2024 Food and Beverage Undisputed 01/23/2026 1121188970 CMS
ADC Therapeutics America, Inc. $60.02 09/27/2024 Food and Beverage Undisputed 01/23/2026 1121188972 CMS
ADC Therapeutics America, Inc. $24.01 09/27/2024 Food and Beverage Undisputed 01/23/2026 1121188974 CMS
ADC Therapeutics America, Inc. $346.69 09/27/2024 Travel and Lodging Undisputed 01/23/2026 1121188978 CMS
ADC Therapeutics America, Inc. $9,800.00 10/31/2024 Consulting Fee Undisputed 01/23/2026 1121188964 CMS
ADC Therapeutics America, Inc. $46.50 12/08/2024 Food and Beverage Undisputed 01/23/2026 1121188918 CMS
Genentech USA, Inc. $37.05 12/09/2024 Food and Beverage Undisputed 01/23/2026 1133084886 CMS
Genmab U.S., Inc. $56.34 12/08/2024 Food and Beverage Undisputed 01/23/2026 1126830536 CMS
Ipsen Biopharmaceuticals, Inc $2,610.00 10/17/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1091993009 CMS
Ipsen Biopharmaceuticals, Inc $110.21 10/17/2024 Food and Beverage Undisputed 01/23/2026 1091993011 CMS
Regeneron Pharmaceuticals, Inc. $127.32 12/10/2024 Food and Beverage Undisputed 01/23/2026 1114399231 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.